- Benzinga•18 hours ago
BioTelemetry, Inc. (NASDAQ: BEAT ) received the Food and Drug Administration's approval for its next generation Mobile Cardiac Outpatient Telemetry device, the MCOT Patch. According to the company, the ...
After hours: 18.810.12 (0.64%) as of 6:16 PM EDT
|Bid||18.20 x 1000|
|Ask||18.95 x 700|
|52wk Range||8.74 - 19.24|
|Day's Range||18.48 - 19.24|
|Avg Vol (3m)||347,220|
As of 4:00 PM EDT. Market closed.